Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Buprenorphine | 24 | 2023 | 665 | 7.400 |
Why?
|
Opioid-Related Disorders | 33 | 2023 | 2178 | 6.090 |
Why?
|
Opiate Substitution Treatment | 16 | 2023 | 452 | 4.260 |
Why?
|
Substance Withdrawal Syndrome | 7 | 2025 | 626 | 3.060 |
Why?
|
Substance Abuse, Intravenous | 6 | 2020 | 531 | 2.710 |
Why?
|
Hallucinogens | 5 | 2024 | 212 | 2.470 |
Why?
|
Alcoholism | 9 | 2025 | 1977 | 2.370 |
Why?
|
Narcotic Antagonists | 9 | 2023 | 590 | 2.340 |
Why?
|
Endocarditis | 5 | 2024 | 349 | 2.060 |
Why?
|
Substance-Related Disorders | 13 | 2024 | 4417 | 1.970 |
Why?
|
Analgesics, Opioid | 20 | 2023 | 3835 | 1.800 |
Why?
|
Behavior, Addictive | 3 | 2023 | 423 | 1.560 |
Why?
|
Fentanyl | 4 | 2023 | 457 | 1.420 |
Why?
|
Benzodiazepines | 4 | 2025 | 1136 | 1.320 |
Why?
|
Methadone | 7 | 2023 | 319 | 1.310 |
Why?
|
Psychiatry | 5 | 2018 | 1715 | 1.030 |
Why?
|
Substance Abuse Detection | 2 | 2018 | 301 | 0.960 |
Why?
|
Naltrexone | 4 | 2023 | 319 | 0.960 |
Why?
|
Glycerophospholipids | 2 | 2024 | 39 | 0.950 |
Why?
|
Naloxone | 2 | 2020 | 373 | 0.920 |
Why?
|
Amantadine | 1 | 2024 | 58 | 0.920 |
Why?
|
Inpatients | 4 | 2021 | 2564 | 0.870 |
Why?
|
Heroin Dependence | 2 | 2017 | 175 | 0.870 |
Why?
|
Memantine | 1 | 2024 | 110 | 0.860 |
Why?
|
Hospitals, General | 3 | 2025 | 802 | 0.810 |
Why?
|
Peer Group | 2 | 2024 | 703 | 0.760 |
Why?
|
Catatonia | 1 | 2024 | 181 | 0.750 |
Why?
|
Cannabinoids | 2 | 2021 | 174 | 0.730 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2023 | 127 | 0.720 |
Why?
|
Bone Diseases, Infectious | 1 | 2020 | 16 | 0.710 |
Why?
|
Metaphor | 1 | 2020 | 41 | 0.690 |
Why?
|
Endocarditis, Bacterial | 2 | 2024 | 434 | 0.690 |
Why?
|
Primary Dysautonomias | 1 | 2020 | 28 | 0.680 |
Why?
|
Physician Impairment | 1 | 2020 | 71 | 0.660 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2024 | 896 | 0.630 |
Why?
|
Cocaine-Related Disorders | 2 | 2024 | 458 | 0.600 |
Why?
|
Dimethoxyphenylethylamine | 2 | 2014 | 3 | 0.600 |
Why?
|
Ketamine | 1 | 2023 | 525 | 0.560 |
Why?
|
Paranoid Disorders | 1 | 2017 | 61 | 0.550 |
Why?
|
Theophylline | 1 | 2017 | 132 | 0.550 |
Why?
|
Injections, Intra-Arterial | 1 | 2017 | 181 | 0.540 |
Why?
|
Substance Abuse Treatment Centers | 1 | 2017 | 154 | 0.540 |
Why?
|
Catheters, Indwelling | 1 | 2019 | 438 | 0.540 |
Why?
|
Crack Cocaine | 1 | 2016 | 33 | 0.540 |
Why?
|
Referral and Consultation | 5 | 2020 | 3617 | 0.540 |
Why?
|
Citrus | 1 | 2016 | 49 | 0.530 |
Why?
|
Treatment Refusal | 1 | 2020 | 433 | 0.530 |
Why?
|
Ambulatory Care | 4 | 2023 | 2778 | 0.530 |
Why?
|
Fellowships and Scholarships | 2 | 2018 | 1135 | 0.530 |
Why?
|
Amphetamines | 1 | 2017 | 143 | 0.520 |
Why?
|
Drug Substitution | 1 | 2019 | 292 | 0.520 |
Why?
|
Radial Artery | 1 | 2017 | 189 | 0.480 |
Why?
|
Lysergic Acid Diethylamide | 1 | 2014 | 50 | 0.470 |
Why?
|
Point-of-Care Systems | 1 | 2023 | 1217 | 0.470 |
Why?
|
Cannabis | 1 | 2021 | 446 | 0.470 |
Why?
|
Delusions | 1 | 2017 | 300 | 0.470 |
Why?
|
Cellulitis | 1 | 2016 | 206 | 0.470 |
Why?
|
Hospitalization | 8 | 2024 | 10806 | 0.460 |
Why?
|
Humans | 76 | 2025 | 765734 | 0.460 |
Why?
|
Self-Help Groups | 1 | 2016 | 194 | 0.450 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2018 | 4057 | 0.450 |
Why?
|
Bacteremia | 1 | 2020 | 989 | 0.430 |
Why?
|
Leukocytosis | 1 | 2014 | 248 | 0.430 |
Why?
|
Patient Compliance | 3 | 2020 | 2692 | 0.420 |
Why?
|
Perinatal Care | 1 | 2015 | 243 | 0.420 |
Why?
|
Arterial Occlusive Diseases | 1 | 2017 | 729 | 0.410 |
Why?
|
Tachycardia | 1 | 2014 | 594 | 0.390 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1084 | 0.390 |
Why?
|
Patient Acceptance of Health Care | 2 | 2016 | 3230 | 0.380 |
Why?
|
Upper Extremity | 1 | 2016 | 682 | 0.370 |
Why?
|
Patient Care Management | 1 | 2014 | 303 | 0.360 |
Why?
|
Appointments and Schedules | 1 | 2015 | 444 | 0.360 |
Why?
|
Psychosomatic Medicine | 1 | 2011 | 72 | 0.350 |
Why?
|
Cooperative Behavior | 2 | 2015 | 1511 | 0.350 |
Why?
|
Adult | 30 | 2024 | 222974 | 0.350 |
Why?
|
Continuity of Patient Care | 1 | 2017 | 1078 | 0.350 |
Why?
|
Gastroplasty | 1 | 2012 | 153 | 0.340 |
Why?
|
Psychotic Disorders | 3 | 2020 | 3272 | 0.340 |
Why?
|
Disclosure | 1 | 2016 | 756 | 0.330 |
Why?
|
Delirium | 1 | 2021 | 1707 | 0.330 |
Why?
|
Program Development | 1 | 2015 | 1296 | 0.320 |
Why?
|
Seizures | 3 | 2019 | 2999 | 0.320 |
Why?
|
Dental Caries | 1 | 2012 | 429 | 0.300 |
Why?
|
Internship and Residency | 3 | 2018 | 5946 | 0.290 |
Why?
|
Adolescent Behavior | 1 | 2016 | 1185 | 0.280 |
Why?
|
Alcohol Drinking | 4 | 2024 | 4041 | 0.280 |
Why?
|
Patient Discharge | 1 | 2020 | 3461 | 0.270 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2022 | 4626 | 0.260 |
Why?
|
Female | 33 | 2024 | 395961 | 0.250 |
Why?
|
Hyperglycemia | 1 | 2014 | 1392 | 0.250 |
Why?
|
Suicide, Attempted | 1 | 2014 | 1408 | 0.250 |
Why?
|
Gastric Bypass | 1 | 2012 | 820 | 0.210 |
Why?
|
Administration, Sublingual | 1 | 2023 | 60 | 0.210 |
Why?
|
Feasibility Studies | 4 | 2020 | 5302 | 0.210 |
Why?
|
Education, Medical, Graduate | 2 | 2015 | 2418 | 0.210 |
Why?
|
Pain | 2 | 2023 | 5074 | 0.210 |
Why?
|
Medicine | 1 | 2011 | 942 | 0.210 |
Why?
|
Male | 27 | 2024 | 363585 | 0.200 |
Why?
|
Physician-Patient Relations | 2 | 2016 | 3278 | 0.200 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 1 | 2023 | 89 | 0.200 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2024 | 450 | 0.190 |
Why?
|
Education, Special | 1 | 2022 | 86 | 0.190 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 7477 | 0.190 |
Why?
|
Primary Health Care | 2 | 2015 | 4737 | 0.190 |
Why?
|
Middle Aged | 17 | 2024 | 222903 | 0.190 |
Why?
|
Curriculum | 1 | 2015 | 3782 | 0.190 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2024 | 373 | 0.190 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2023 | 157 | 0.190 |
Why?
|
Liver Transplantation | 2 | 2023 | 2412 | 0.180 |
Why?
|
Motivation | 2 | 2022 | 2020 | 0.180 |
Why?
|
Obesity, Morbid | 1 | 2012 | 1293 | 0.180 |
Why?
|
Ethanol | 2 | 2024 | 1324 | 0.180 |
Why?
|
Massachusetts | 2 | 2024 | 8876 | 0.180 |
Why?
|
Attitude of Health Personnel | 1 | 2014 | 3926 | 0.170 |
Why?
|
Punishment | 1 | 2021 | 95 | 0.170 |
Why?
|
Loperamide | 1 | 2019 | 10 | 0.160 |
Why?
|
Methocarbamol | 1 | 2019 | 8 | 0.160 |
Why?
|
Promethazine | 1 | 2019 | 29 | 0.160 |
Why?
|
Sympatholytics | 1 | 2019 | 81 | 0.160 |
Why?
|
Antipruritics | 1 | 2019 | 31 | 0.160 |
Why?
|
Delayed-Action Preparations | 1 | 2023 | 967 | 0.160 |
Why?
|
Powders | 1 | 2019 | 78 | 0.160 |
Why?
|
Stroke | 1 | 2021 | 9747 | 0.160 |
Why?
|
Antidiarrheals | 1 | 2019 | 46 | 0.160 |
Why?
|
Tobacco Use Disorder | 1 | 2024 | 708 | 0.150 |
Why?
|
Health Services | 1 | 2023 | 756 | 0.150 |
Why?
|
Ondansetron | 1 | 2019 | 95 | 0.150 |
Why?
|
Pregnancy Complications | 1 | 2012 | 2969 | 0.150 |
Why?
|
Muscle Relaxants, Central | 1 | 2019 | 94 | 0.150 |
Why?
|
Clonidine | 1 | 2019 | 164 | 0.150 |
Why?
|
Injections, Subcutaneous | 1 | 2019 | 682 | 0.150 |
Why?
|
Pilot Projects | 3 | 2023 | 8732 | 0.140 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2020 | 170 | 0.140 |
Why?
|
Alcohol-Related Disorders | 1 | 2020 | 242 | 0.140 |
Why?
|
Retrospective Studies | 9 | 2024 | 81457 | 0.140 |
Why?
|
Antiemetics | 1 | 2019 | 185 | 0.140 |
Why?
|
Comorbidity | 3 | 2022 | 10567 | 0.140 |
Why?
|
Health Services Accessibility | 1 | 2015 | 5506 | 0.140 |
Why?
|
Injections | 1 | 2020 | 839 | 0.130 |
Why?
|
Secondary Prevention | 1 | 2023 | 1472 | 0.130 |
Why?
|
Somatoform Disorders | 1 | 2019 | 425 | 0.130 |
Why?
|
Medical History Taking | 1 | 2020 | 778 | 0.130 |
Why?
|
Heroin | 1 | 2016 | 120 | 0.130 |
Why?
|
Drug Administration Schedule | 2 | 2020 | 4850 | 0.130 |
Why?
|
Professional-Patient Relations | 1 | 2021 | 724 | 0.120 |
Why?
|
Young Adult | 6 | 2018 | 59852 | 0.120 |
Why?
|
Sensation | 1 | 1997 | 331 | 0.120 |
Why?
|
Outpatients | 1 | 2023 | 1594 | 0.120 |
Why?
|
Anisoles | 1 | 2014 | 6 | 0.120 |
Why?
|
Barbiturates | 1 | 2015 | 113 | 0.120 |
Why?
|
Hospital Administration | 1 | 2018 | 352 | 0.120 |
Why?
|
Anticonvulsants | 1 | 2025 | 1918 | 0.120 |
Why?
|
Risperidone | 1 | 2017 | 383 | 0.120 |
Why?
|
Phenethylamines | 1 | 2014 | 95 | 0.120 |
Why?
|
Hypertension | 1 | 2014 | 8626 | 0.110 |
Why?
|
Culture | 1 | 2018 | 622 | 0.110 |
Why?
|
Physicians | 1 | 2012 | 4587 | 0.110 |
Why?
|
Benzylamines | 1 | 2014 | 251 | 0.110 |
Why?
|
Chromatography, Liquid | 1 | 2017 | 990 | 0.110 |
Why?
|
Psychotherapy | 2 | 2019 | 1646 | 0.110 |
Why?
|
Checklist | 1 | 2020 | 847 | 0.110 |
Why?
|
Creatine Kinase | 1 | 2014 | 682 | 0.100 |
Why?
|
Drug Utilization | 1 | 2018 | 1187 | 0.100 |
Why?
|
Hypnotics and Sedatives | 1 | 2020 | 1191 | 0.100 |
Why?
|
Data Collection | 2 | 2011 | 3318 | 0.100 |
Why?
|
Drug Hypersensitivity | 1 | 2020 | 903 | 0.100 |
Why?
|
Natural Language Processing | 1 | 2021 | 1198 | 0.100 |
Why?
|
Oxycodone | 1 | 2012 | 143 | 0.090 |
Why?
|
Tandem Mass Spectrometry | 1 | 2017 | 1193 | 0.090 |
Why?
|
Leukocyte Count | 1 | 2014 | 1602 | 0.090 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2020 | 1496 | 0.080 |
Why?
|
Adaptation, Psychological | 1 | 2020 | 2660 | 0.080 |
Why?
|
United States | 8 | 2020 | 72898 | 0.080 |
Why?
|
Odds Ratio | 2 | 2020 | 9647 | 0.080 |
Why?
|
Electrocardiography | 1 | 2023 | 6401 | 0.080 |
Why?
|
Central Nervous System Stimulants | 1 | 2017 | 1167 | 0.080 |
Why?
|
Medical Oncology | 2 | 2018 | 2339 | 0.080 |
Why?
|
Pregnancy | 3 | 2015 | 30248 | 0.070 |
Why?
|
Thrombolytic Therapy | 1 | 2017 | 2059 | 0.070 |
Why?
|
Memory | 1 | 1997 | 2191 | 0.070 |
Why?
|
Headache | 1 | 2015 | 1260 | 0.070 |
Why?
|
Neuropsychological Tests | 1 | 2020 | 7123 | 0.070 |
Why?
|
Patient Readmission | 1 | 2020 | 3286 | 0.070 |
Why?
|
Cognition | 1 | 2023 | 7048 | 0.060 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2012 | 1987 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3412 | 0.060 |
Why?
|
Mental Disorders | 3 | 2013 | 6869 | 0.060 |
Why?
|
Pandemics | 1 | 2023 | 8703 | 0.050 |
Why?
|
Antipsychotic Agents | 1 | 2017 | 3078 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15883 | 0.050 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6307 | 0.050 |
Why?
|
Patient Satisfaction | 1 | 2015 | 3478 | 0.050 |
Why?
|
Mental Health Services | 1 | 2013 | 1729 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 12949 | 0.050 |
Why?
|
Depressive Disorder | 1 | 2013 | 3712 | 0.040 |
Why?
|
Adjustment Disorders | 1 | 2020 | 68 | 0.040 |
Why?
|
Weight Loss | 1 | 2012 | 2710 | 0.040 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2020 | 300 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2020 | 65180 | 0.040 |
Why?
|
Hospitals, Psychiatric | 1 | 2020 | 319 | 0.040 |
Why?
|
Chronic Disease | 1 | 2013 | 9351 | 0.040 |
Why?
|
Adolescent | 2 | 2016 | 88781 | 0.030 |
Why?
|
Information Systems | 1 | 2018 | 400 | 0.030 |
Why?
|
Risk Factors | 2 | 2015 | 74831 | 0.030 |
Why?
|
Age Factors | 1 | 2013 | 18375 | 0.030 |
Why?
|
Inservice Training | 1 | 2018 | 375 | 0.030 |
Why?
|
Personality Disorders | 1 | 2020 | 727 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2015 | 26332 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2019 | 1589 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2013 | 22224 | 0.030 |
Why?
|
Prevalence | 1 | 2012 | 15833 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2020 | 1441 | 0.030 |
Why?
|
Advisory Committees | 1 | 2018 | 796 | 0.030 |
Why?
|
Nausea | 1 | 2017 | 680 | 0.030 |
Why?
|
Patient-Centered Care | 1 | 2024 | 1458 | 0.030 |
Why?
|
Standard of Care | 1 | 2017 | 567 | 0.020 |
Why?
|
Functional Laterality | 1 | 1997 | 2243 | 0.020 |
Why?
|
Brain | 1 | 1997 | 27178 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2012 | 39180 | 0.020 |
Why?
|
Program Evaluation | 1 | 2018 | 2501 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2020 | 1945 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2020 | 2736 | 0.020 |
Why?
|
Medicare Part C | 1 | 2013 | 335 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10730 | 0.020 |
Why?
|
Neoplasms | 1 | 2017 | 22345 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8528 | 0.020 |
Why?
|
Aged | 3 | 2020 | 171050 | 0.020 |
Why?
|
Societies, Medical | 1 | 2017 | 3955 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2012 | 21053 | 0.010 |
Why?
|
Quality Improvement | 1 | 2018 | 3854 | 0.010 |
Why?
|
Bipolar Disorder | 1 | 2020 | 5125 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 8062 | 0.010 |
Why?
|
Depressive Disorder, Major | 1 | 2020 | 4809 | 0.010 |
Why?
|
Medicare | 1 | 2020 | 6821 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7424 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 10385 | 0.010 |
Why?
|
Algorithms | 1 | 2021 | 14061 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 26284 | 0.010 |
Why?
|
Logistic Models | 1 | 2013 | 13261 | 0.010 |
Why?
|
Quality of Life | 1 | 2019 | 13462 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2013 | 59459 | 0.000 |
Why?
|